Aberdeen Group plc Has $29.34 Million Position in Eyepoint Pharmaceuticals, Inc. $EYPT

Aberdeen Group plc boosted its position in Eyepoint Pharmaceuticals, Inc. (NASDAQ: EYPT) by 101.6% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,605,984 shares of the company's stock after purchasing an additional 809,182 shares during the quarter. Aberdeen Group plc owned